Format

Send to

Choose Destination
Biochim Biophys Acta. 2016 Aug;1866(1):76-86. doi: 10.1016/j.bbcan.2016.06.004. Epub 2016 Jun 22.

Cycling hypoxia: A key feature of the tumor microenvironment.

Author information

1
URBC-NARILIS, University of Namur, 61 rue de Bruxelles, 5000 Namur, Belgium. Electronic address: carine.michiels@unamur.be.
2
URBC-NARILIS, University of Namur, 61 rue de Bruxelles, 5000 Namur, Belgium.
3
Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, 53 Avenue Mounier, B1.53.09, B-1200 Brussels, Belgium. Electronic address: olivier.feron@uclouvain.be.

Abstract

A compelling body of evidence indicates that most human solid tumors contain hypoxic areas. Hypoxia is the consequence not only of the chaotic proliferation of cancer cells that places them at distance from the nearest capillary but also of the abnormal structure of the new vasculature network resulting in transient blood flow. Hence two types of hypoxia are observed in tumors: chronic and cycling (intermittent) hypoxia. Most of the current work aims at understanding the role of chronic hypoxia in tumor growth, response to treatment and metastasis. Only recently, cycling hypoxia, with spatial and temporal fluctuations in oxygen levels, has emerged as another key feature of the tumor environment that triggers different responses in comparison to chronic hypoxia. Either type of hypoxia is associated with distinct effects not only in cancer cells but also in stromal cells. In particular, cycling hypoxia has been demonstrated to favor, to a higher extent than chronic hypoxia, angiogenesis, resistance to anti-cancer treatments, intratumoral inflammation and tumor metastasis. These review details these effects as well as the signaling pathway it triggers to switch on specific transcriptomic programs. Understanding the signaling pathways through which cycling hypoxia induces these processes that support the development of an aggressive cancer could convey to the emergence of promising new cancer treatments.

KEYWORDS:

Angiogenesis; Cancer microenvironment; Cycling/intermittent hypoxia; Inflammation; ROS production; Transcriptional response

PMID:
27343712
DOI:
10.1016/j.bbcan.2016.06.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center